• Published On: 10/22/2024

  Lame Duck (New) Outlook Is Skinny

  Read Article
• Published On: 10/18/2024

  Kamala v Trump on Healthcare

  Read Article
• Published On: 10/16/2024

  FDA Rare Disease Hub Update

  Read Article
• Published On: 10/07/2024

  Abbott and Edwards Lifesciences Likely Successful TCET Candidates

  Read Article
• Published On: 10/03/2024

  2027 Negotiated Drug Prices Potentially Start Lower?

  Read Article
• Published On: 10/02/2024

  FDA AdComm Reform is Not Coming Any Time Soon

  Read Article
• Published On: 10/02/2024

  Deja Vu: Healthcare Takes Backseat in Vance v. Walz

  Read Article
• Published On: 09/29/2024

  Medicare Advantage Landscape Files 2025

  Read Article
• Published On: 09/26/2024

  Medicaid MCO Guidance On Prior Auth

  Read Article
• Published On: 09/24/2024

  Novo CEO Testifies Today on GLP-1 Prices

  Read Article
• Published On: 09/23/2024

  Rare Pediatric Disease PRV Likely to Be Extended via Latest CR

  Read Article
• Published On: 09/23/2024

  Mixed Bag: Medicaid Drug & Rebate Final Rules

  Read Article
• Published On: 09/22/2024

  Appellate Court Gives PhRMA’s IRA Argument A Chance

  Read Article
• Published On: 09/20/2024

  ALERT: FTC Sues Big 3 PBMs

  Read Article
• Published On: 09/20/2024

  BIOSECURE Omitted from Senate NDAA Manager’s Amendment

  Read Article
• Published On: 09/18/2024

  House E&C Clears Telehealth Bill w/ PBM, Lab Payfors

  Read Article
• Published On: 09/12/2024

  PBM Reform (Still) Likely at Year End

  Read Article
• Published On: 09/09/2024

  House Passes BIOSECURE Act

  Read Article
• Published On: 09/03/2024

  BIOSECURE Heats… Then Cools?

  Read Article
• Published On: 08/29/2024

  Health Policy Catalyst Update – Aug. 29, 2024

  Read Article

Previous123Next